skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover idioma: Chinês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Real-world Study on the Expression Characteristics of PD-L1 in Patients 
with Advanced EGFR Positive NSCLC and Its Relationship with the 
Therapeutic Efficacy of EGFR-TKIs
A Real-world Study on the Expression Characteristics of PD-L1 in Patients 
with Advanced EGFR Positive NSCLC and Its Relationship with the 
Therapeutic Efficacy of EGFR-TKIs
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Real-world Study on the Expression Characteristics of PD-L1 in Patients 
with Advanced EGFR Positive NSCLC and Its Relationship with the 
Therapeutic Efficacy of EGFR-TKIs

Chen, Ran ; Gao, Xiang ; Xu, Fudong ; Zhang, Shucai ; Ma, Li ; Hu, Bo

Zhongguo fei ai za zhi, 2023-03, Vol.26 (3), p.217-227 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association; Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
2
Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance
Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance

Yang, Lan ; Hu, Honglin ; Deng, Ying ; Bai, Yifeng

Zhongguo fei ai za zhi, 2014-11, Vol.17 (11), p.769-777 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
3
Dynamic Changes of Circulating Tumor DNA in Peripheral Blood Predict the Efficacy of TKI in the Treatment of Lung Adenocarcinoma with EGFR Mutation
Dynamic Changes of Circulating Tumor DNA in Peripheral Blood Predict the Efficacy of TKI in the Treatment of Lung Adenocarcinoma with EGFR Mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dynamic Changes of Circulating Tumor DNA in Peripheral Blood Predict the Efficacy of TKI in the Treatment of Lung Adenocarcinoma with EGFR Mutation

Song, Yuguang ; Wang, Shuo ; Zhao, Yanjie ; Jiang, Ni ; Qiao, Guoliang ; Zhao, Jing ; Di, Yan ; Wang, Xiaoli ; Ren, Jun

Zhongguo fei ai za zhi, 2019-09, Vol.22 (9), p.568-573 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
4
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer 
and Brain Metastases
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer 
and Brain Metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of Patients with ALK-positive Non-small Cell Lung Cancer 
and Brain Metastases

Lv, Jialin ; Zhang, Quan ; Qin, Na ; Yang, Xinjie ; Zhang, Xinyong ; Wu, Yuhua ; Li, Xi ; Zhang, Hui ; Wang, Jinghui ; Zhang, Shucai

Zhongguo fei ai za zhi, 2016-08, Vol.19 (8), p.519-524 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
5
Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations
Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations

Wang, Qunhui ; Zheng, Hua ; Hu, Fanbin ; Zhang, Hongmei ; Hu, Ying ; Li, Jie ; Zhang, Tongmei ; Liu, Zan ; Lu, Baohua ; Hu, Aimin ; Li, Baolan

Zhongguo fei ai za zhi, 2016-08, Vol.19 (8), p.550-558 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
6
Crizotinib Treatment Combined with Resection and Whole-brain Radiation Therapy 
in A ROS1 Rearranged Lung Adenocarcinoma with Brain Metastasis: 
Case Report and Literature Review
Crizotinib Treatment Combined with Resection and Whole-brain Radiation Therapy 
in A ROS1 Rearranged Lung Adenocarcinoma with Brain Metastasis: 
Case Report and Literature Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Crizotinib Treatment Combined with Resection and Whole-brain Radiation Therapy 
in A ROS1 Rearranged Lung Adenocarcinoma with Brain Metastasis: 
Case Report and Literature Review

Zhang, Min ; Nie, Ligong ; Zhang, Jiayong

Zhongguo fei ai za zhi, 2016-08, Vol.19 (8), p.525-529 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
7
Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated 
Non-small Cell Lung Cancer and Brain Metastases
Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated 
Non-small Cell Lung Cancer and Brain Metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated 
Non-small Cell Lung Cancer and Brain Metastases

Liu, Guimei ; Zhang, Xinyong ; Tian, Cuimeng ; Xia, Guangrong ; Liu, Ping ; Zhang, Quan ; Li, Xi ; Zhang, Hui ; Qin, Na ; Wang, Jinghui ; Zhang, Shucai

Zhongguo fei ai za zhi, 2016-08, Vol.19 (8), p.501-507 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
8
A nuclear-encoded mitochondrial gene AtCIB22 is essential for plant development in Arabidopsis
A nuclear-encoded mitochondrial gene AtCIB22 is essential for plant development in Arabidopsis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A nuclear-encoded mitochondrial gene AtCIB22 is essential for plant development in Arabidopsis

Han, Lihua ; Qin, Genji ; Kang, Dingming ; Chen, Zhangliang ; Gu, Hongya ; Qu, Li-Jia

Journal of genetics and genomics, 2010-10, Vol.37 (10), p.667-683 [Periódico revisado por pares]

China: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor
Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor

Zheng, Lei ; Lin, Baochai ; Song, Zhengbo ; Xie, Fangjun ; Hong, Wei ; Feng, Jianguo ; Shao, Lan ; Zhang, Yingping

Zhongguo fei ai za zhi, 2013-12, Vol.16 (12), p.632-638 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por
10
Role of erlotinib 100 mg/d in the treatment of advanced adenocarcinoma lung cancer failed to previous chemotherapy
Role of erlotinib 100 mg/d in the treatment of advanced adenocarcinoma lung cancer failed to previous chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of erlotinib 100 mg/d in the treatment of advanced adenocarcinoma lung cancer failed to previous chemotherapy

Shi, Chunlei ; Han, Baohui ; Gu, Aiqin ; Xiong, Liwen ; Shen, Jie

Zhongguo fei ai za zhi, 2011-06, Vol.14 (6), p.529-533 [Periódico revisado por pares]

China: Chinese Anti-Cancer Association; Chinese Antituberculosis Association

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.